Takeda Pharmaceutical TAK
NYSE TAK
$18.17 -0.17 (-0.93%)
At close: Aug 20, 2026 · 2:00 PM UTC

Takeda Pharmaceutical (TAK) Capital Leases (2017 - 2019)

Takeda Pharmaceutical (TAK) Capital Leases (2017 - 2019) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2019 -15.81 Mn
Dec 31, 2018 -14.18 Mn
Dec 31, 2017 -17.20 Mn